Jazz Pharmaceuticals Plc (NASDAQ:JAZZ)

About the company

Jazz Pharmaceuticals Plc operates as a specialty biopharmaceutical company, which focuses on the identification, development and commercialization of pharmaceutical products in the areas of narcolepsy, oncology, pain and psychiatry. Its product portfolio includes: XYREM, ERWINAZETM, PRIALT, intrathecal infusion, FAZACLO and LUVOX CR. The company was founded by Bruce C. Cozadd in March 2003 and is headquartered in Dublin, Ireland.

Sector

Health Technology

Industry

Pharmaceuticals: Other

Employees

1620

CEO

Bruce C. Cozadd

Exchange

NASDAQ

Website

http://www.jazzpharma.com

$2B

Total Revenue

2K

Employees

$6B

Market Capitalization

22.36

Price/Earning ratio

Stock price

Gross Margin (in %)

Total gross margin

$2065M

Operating Margin (in %)

Total operating margin

$602M

Net Margin (in %)

Total net margin

$280M

Dividend Yield (in %)

Dividend per share

$0

Industry peers

Name Ticker Market capitalization (in USD Million) Revenues (in USD Million) Price/Book Price/Earning Net margin (in %)
Catalent, Inc. CTLT 11818.68 2872.00 5.94 113.31 3.63
Horizon Therapeutics Plc HZNP 11795.70 1376.00 5.03 18.60 43.06
Perrigo Co. Plc PRGO 7706.25 4837.00 1.32 52.57 3.02
Bausch Health Cos., Inc. BHC 6142.20 8597.00 8.57 -3.25 -21.96
Jazz Pharmaceuticals Plc JAZZ 6116.67 2188.00 2.11 22.36 12.81
United Therapeutics Corp. UTHR 4985.85 1443.00 1.73 9.62 36.59
MyoKardia, Inc. MYOK 4168.52 34.00 12.11 -13.45 -201.73
Axsome Therapeutics, Inc. AXSM 2779.70 None 18.86 -30.90 None
Pacira Biosciences, Inc. PCRX 2334.36 435.00 6.26 -5558.00 -0.02
SAGE Therapeutics, Inc. SAGE 2269.80 9.00 2.67 -3.51 -413.06
ArQule, Inc. ARQL 2240.00 5.00 15.75 -55.56 -808.06
Corcept Therapeutics, Inc. CORT 1989.82 335.00 4.57 18.75 31.64
Prestige Consumer Healthcare, Inc. PBH 1853.85 963.00 1.56 13.08 14.77
Ironwood Pharmaceuticals, Inc. IRWD 1604.54 440.00 -22.71 18.93 19.14
Innoviva, Inc. INVA 1559.40 285.00 3.69 8.07 66.41
Madrigal Pharmaceuticals, Inc. MDGL 1551.15 0.00 4.14 -15.19 -624.74
Revolution Medicines, Inc. RVMD 1498.60 48.00 3.89 -21.17 -146.29
Intercept Pharmaceuticals, Inc. ICPT 1390.40 272.00 -41.38 -4.05 -127.53
Portola Pharmaceuticals, Inc. PTLA 1329.78 121.00 19.53 -4.77 -232.73
Supernus Pharmaceuticals, Inc. SUPN 1290.60 402.00 2.05 11.06 28.90
Zogenix, Inc. ZGNX 1233.00 5.00 3.37 -2.90 -241.62
Theravance Biopharma, Inc. TBPH 1208.97 88.00 -8.48 -4.90 -280.80
Revance Therapeutics, Inc. RVNC 1139.28 0.00 4.50 -6.11 41.82
Amphastar Pharmaceuticals, Inc. AMPH 993.23 327.00 2.48 19.49 15.90
BellRing Brands, Inc. BRBR 805.74 954.00 -0.44 6.11 13.98
Endo International Plc ENDP 775.20 3014.00 -1.06 -2.76 -9.09
Assembly Biosciences, Inc. ASMB 684.40 16.00 3.07 -6.88 -601.75
Eagle Pharmaceuticals, Inc. EGRX 679.42 192.00 3.65 269.61 1.29
Aerie Pharmaceuticals, Inc. AERI 612.26 79.00 4.86 -3.03 -252.92
Intersect ENT, Inc. XENT 571.84 102.00 5.40 -11.46 -48.61
Collegium Pharmaceutical, Inc. COLL 566.27 299.00 4.05 -43.83 -4.21
Catalyst Pharmaceuticals, Inc. CPRX 511.46 119.00 4.98 11.66 36.09
Anika Therapeutics, Inc. ANIK 508.62 125.00 1.76 18.35 22.73
BioDelivery Sciences International, Inc. BDSI 391.92 130.00 5.61 -53.25 -5.01
ANI Pharmaceuticals, Inc. ANIP 341.64 203.00 1.75 -219.00 -0.67
Albireo Pharma, Inc. ALBO 318.89 11.00 3.24 -4.17 -730.55
MEI Pharma, Inc. MEIP 281.37 5.00 4.84 -7.21 -539.48
Mallinckrodt Plc MNK 231.00 3037.00 0.12 -0.19 -39.56
Agile Therapeutics, Inc. AGRX 143.96 None 2.35 -6.97 None
Marinus Pharmaceuticals, Inc. MRNS 140.49 0.00 6.37 -2.08 None
Cerecor, Inc. CERC 114.54 7.00 7.32 -5.08 -429.22
Ampio Pharmaceuticals, Inc. AMPE 97.24 1.00 68.00 -5.23 None
Evoke Pharma, Inc. EVOK 87.12 397.00 30.25 -12.96 -0.76
AcelRx Pharmaceuticals, Inc. ACRX 84.00 2.00 -1.54 -1.50 -644.25
Aclaris Therapeutics, Inc. ACRS 81.59 4.00 1.43 -0.59 None
Zynerba Pharmaceuticals, Inc. ZYNE 78.43 0.00 1.29 -2.19 -699.94
CTI BioPharma Corp. CTIC 73.75 3.00 3.29 -1.79 -111.83
Adamas Pharmaceuticals, Inc. ADMS 73.64 57.00 -4.70 -0.79 -160.44
Cassava Sciences, Inc. SAVA 69.35 41.00 3.65 -15.21 76.71
Oramed Pharmaceuticals, Inc. ORMP 65.36 3.00 2.37 -6.04 -398.34
Acasti Pharma, Inc. ACST 59.50 0.00 5.00 -2.33 -611.47
Cumberland Pharmaceuticals, Inc. CPIX 47.70 47.00 0.97 -10.60 -9.59
Natural Alternatives International, Inc. NAII 47.32 114.00 0.65 -12.52 -3.19
SCYNEXIS, Inc. SCYX 46.24 0.00 9.71 -1.19 -30.84
IsoRay, Inc. ISR 42.88 9.00 8.00 -12.80 -36.08
Lipocine, Inc. LPCN 36.90 0.00 8.79 -2.46 None
Neos Therapeutics, Inc. NEOS 31.92 65.00 -2.46 -1.82 -26.74
PLx Pharma, Inc. PLXP 25.29 0.00 -2.42 -2.68 119.04
CytRx Corp. CYTR 22.11 0.00 1.60 -3.19 408.46
EyeGate Pharmaceuticals, Inc. EYEG 20.16 3.00 2.51 -1.70 -264.21
Regulus Therapeutics, Inc. RGLS 16.17 0.00 1.43 -0.75 -272.13
Tetraphase Pharmaceuticals, Inc. TTPH 11.95 8.00 0.64 -0.14 -798.18
Intec Pharma Ltd. NTEC 11.25 None 1.45 -0.26 None
Hepion Pharmaceuticals, Inc. HEPA 10.17 None 1.79 3.05 None
Sonoma Pharmaceuticals, Inc. SNOA 6.77 19.00 1.53 -3.40 -15.56
VIVUS, Inc. VVUS 6.71 73.00 -0.15 -0.23 -39.28
KemPharm, Inc. KMPH 6.02 15.00 -0.17 -0.35 -120.48
Tonix Pharmaceuticals Holding Corp. TNXP 3.96 None 0.99 -0.08 None
Ritter Pharmaceuticals, Inc. RTTR 0.45 None 0.17 -0.03 None

Latest insider transactions

Date Role Name Transaction Quantity Quantity Owned After

Did Hedge Funds Make The Right Call On Jazz Pharmaceuticals Plc (JAZZ)?

3d ago, source: YAHOO!

We know that hedge funds generate strong, risk-adjusted returns over the long run, which is why imitating the picks that they ...

Jazz Pharmaceuticals: Buy, Sell, Or Hold

5d ago, source: Seeking Alpha

Jazz Pharmaceuticals plc is trading at 9x revised 2020E Adj. EPS after dropping ~30% since mid-January. The market fears an ...

National Comprehensive Cancer Network® adds Zepzelca™ (lurbinectedin) to Clinical Practice Guidelines in Oncology

2d ago, source: PR Newswire

PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that Zepzelca™ (lurbinectedin) was added by the ...

Jazz Pharmaceuticals (JAZZ)

8d ago, source: Forbes

Jazz Pharmaceuticals Plc operates as a specialty biopharmaceutical company, which focuses on the identification, development and commercialization of pharmaceutical products. The company has a ...

Jazz's (JAZZ) New Sleep Drug Sunosi Gets Schedule IV Status

12d ago, source: YAHOO!

Jazz Pharmaceuticals plc JAZZ announced that the U.S. Drug Enforcement Agency (“DEA”) has designated its recently approved sleep drug, Sunosi (solriamfetol), as a Schedule IV medicine.

Jazz Pharmaceuticals Announces Agreement To Acquire Rights To Defibrotide In The Americas From Sigma-Tau Pharmaceuticals, Inc.

13d ago, source: PR Newswire

DUBLIN, July 2, 2014 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the company has signed a definitive agreement with Sigma-Tau Pharmaceuticals, Inc. (Sigma-Tau ...

Jazz Pharmaceuticals PLC JAZZ

9d ago, source: Morningstar%2c Inc.

Jazz reported mixed first-quarter results, with key drug Xyrem for sleep disorders driving top-line growth, but recently launched Sunosi posting disappointing sales numbers. Further, the company's ...



Portfolio items

Follow companies to create your optimal portfolio.
or
Refresh this page to see your newly added stocks.